Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate
Makaleler > Tam Makale · 2005
Yazarlar: SERDAR PAŞA, Seray TÖZ, HÜSEYİN VOYVODA, Yusuf ÖZBEL
VETERINARY PARASITOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2005, cilt 128, ss 243-249
DOI: 10.1016/j.vetpar.2004.12.002
Özet
Seven dogs with parasitologically proven clinical visceral leishmaniosis (Leishmania infantum infection) were treated with a combination of allopurinol and sodium stibogluconate. The dogs received first orally 15 mg/kg of allopurinol every 12 h until the clinical signs improved, in the following 1 month period allopurinol at same dose and subcutaneously 30 mg/kg of sodium stibogluconate combination were given daily and at the end of the combined treatment, allopurinol was continued alone at the same dose till the end of 8 months. During the treatment period, dogs were supported by additional proteins, vitamins, and minerals. A long acting insecticide (collar or drop) was also used in order to prevent further parasite transmission. Follow-up was maintained by clinical, clinicopathological evaluation, and parasitological examination of lymph node, serology using the indirect immunofluorescent antibody test (IFAT). Before treatment commenced, the most important clinical signs were exfoliative dermatitis, ulcerations, peripheral lymhadenopathy, pale mucous membranes, weight loss, and ocular lesions. Clinicopathological findings included commonly anaemia, hyperproteinaemia, hyperglobulinaemia and hypoalbuminaemia. Before the treatment, amastigotes were seen in six of the seven dogs by examination of lymph node aspiration, and IFAT-titers were positive in all dogs.